We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
MasterCraft Boat Holdings
MCFT
$590M
| $574K | ﹤0.01% |
21,581
-1,290
| -6% | -$35.8K |
|
|
PRVB
2427
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $574K | ﹤0.01% |
54,739
-1,015
| -2% | -$14.3K |
|
2428
Civista Bancshares
CIVB
$589M
| $573K | ﹤0.01% |
24,974
-900
| -3% | -$18.1K |
|
2429
Capital City Bank Group
CCBG
$890M
| $571K | ﹤0.01% |
21,963
-820
| -4% | -$20.8K |
|
|
MGI
2430
DELISTED
MoneyGram International, Inc. New
MGI
| $570K | ﹤0.01% |
86,792
-2,717
| -3% | -$19.9K |
|
2431
EverQuote
EVER
$906M
| $569K | ﹤0.01% |
15,666
-1,261
| -7% | -$53.7K |
|
|
SEI
2432
Solaris Energy Infrastructure
SEI
$3.82B
| $568K | ﹤0.01% |
46,281
-2,930
| -6% | -$33.4K |
|
2433
Bridgewater Bancshares
BWB
$603M
| $565K | ﹤0.01% |
34,995
-1,910
| -5% | -$28.2K |
|
|
FPI
2434
Farmland Partners
FPI
$432M
| $565K | ﹤0.01% |
50,365
-2,420
| -5% | -$27.6K |
|
2435
Vaxcyte
PCVX
$8.64B
| $565K | ﹤0.01% |
28,583
+6,186
| +28% | +$156K |
|
2436
Ardelyx
ARDX
$997M
| $564K | ﹤0.01% |
85,145
-10,480
| -11% | -$71.9K |
|
2437
Metropolitan Bank Holding Corp
MCB
$1.15B
| $562K | ﹤0.01% |
11,167
-30
| -0.3% | -$1.39K |
|
|
RJET
2438
Republic Airways Holdings
RJET
$1B
| $561K | ﹤0.01% |
2,782
+59
| +2% | +$9.27K |
|
|
LAND
2439
Gladstone Land Corp
LAND
$360M
| $556K | ﹤0.01% |
30,388
-960
| -3% | -$16.6K |
|
2440
Astrana Health
ASTH
$1.77B
| $556K | ﹤0.01% |
20,531
-1,345
| -6% | -$32.4K |
|
2441
First Internet Bancorp
INBK
$255M
| $555K | ﹤0.01% |
15,757
-720
| -4% | -$24.1K |
|
2442
The Joint Corp
JYNT
$119M
| $554K | ﹤0.01% |
11,462
-78
| -0.7% | -$2.92K |
|
2443
Willdan Group
WLDN
$1.3B
| $553K | ﹤0.01% |
13,472
-610
| -4% | -$28.1K |
|
|
CPRX
2444
DELISTED
Catalyst Pharmaceutical
CPRX
| $551K | ﹤0.01% |
119,546
-6,740
| -5% | -$26.8K |
|
2445
Oric Pharmaceuticals
ORIC
$1.4B
| $551K | ﹤0.01% |
22,487
+495
| +2% | +$15.6K |
|
2446
Vital Farms
VITL
$525M
| $551K | ﹤0.01% |
25,238
+11,624
| +85% | +$305K |
|
2447
BioAtla
BCAB
$5.74M
| $549K | ﹤0.01% |
+216
| New | +$554K |
|
|
DX
2448
Dynex Capital
DX
$3.21B
| $549K | ﹤0.01% |
29,015
-3,959
| -12% | -$72.9K |
|
|
GAN
2449
DELISTED
GAN Ltd
GAN
| $547K | ﹤0.01% |
30,058
+10,444
| +53% | +$265K |
|
2450
Greif Class B
GEF.B
$4.21B
| $547K | ﹤0.01% |
9,564
-366
| -4% | -$19.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.